Reply to Binghao Zhao, Ruidong Zhang, and Jiaming Wu's Letter to the Editor re: Ana Cavillon, Damien Pouessel, Nadine Houede, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011

被引：0

作者：

Cavillon, Ana ^{[1
]}

Porcher, Raphael ^{[2
,3
]}

Filleron, Thomas ^{[1
]}

机构：

[1] IUCT Oncopole, Inst Claudius Regaud, Biostat & Hlth Data Sci Unit, 1 Ave Irene Joliot Curie, F-31059 Toulouse, France

[2] Univ Paris Cite, Ctr Rech Epidemiol & Stat, CRESS UMR1153, Paris, France

[3] AP HP, Ctr Epidemiol Clin, Paris, France

来源：

EUROPEAN UROLOGY | 2023年 / 84卷 / 01期

关键词：

D O I：

10.1016/j.eururo.2023.04.016

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E22 / E23

页数：2

共 3 条

[1] Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214Immune Checkpoint Inhibitor Trials
Zhao, Binghao
Zhang, Ruidong
Wu, Jiamin
[J]. EUROPEAN UROLOGY, 2023, 84 (01) : E20 - E21
[2] Reply to Johanna Noel, Olivier Huillard, and Francois Goldwasser's Letter to the Editor re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006. Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?
Mori, Keiichiro
Schmidinger, Manuela
Egawa, Shin
Gust, Kilian M.
Shariat, Shahrokh F.
[J]. EUROPEAN UROLOGY, 2021, 79 (04) : E113 - E114
[3] Reply to Cosimo De Nunzio, Giacomo Novara, Rocco Damiano, Riccardo Bartoletti, Andrea Tubaro, and Vincenzo Ficarra's Letter to the Editor re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002. New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-Blockers
Russo, Giorgio Ivan
Cacciamani, Giovanni
Cocci, Andrea
[J]. EUROPEAN UROLOGY FOCUS, 2021, 7 (03): : 662 - 663

← 1 →